Glaxosmithkline Pharma standalone net profit rises 3.04% in the March 2016 quarter

Sales rise 11.83% to Rs 686.06 crore

Net profit of Glaxosmithkline Pharma rose 3.04% to Rs 105.98 crore in the quarter ended March 2016 as against Rs 102.85 crore during the previous quarter ended March 2015. Sales rose 11.83% to Rs 686.06 crore in the quarter ended March 2016 as against Rs 613.47 crore during the previous quarter ended March 2015.

For the full year,net profit declined 20.45% to Rs 375.21 crore in the year ended March 2016 as against Rs 471.65 crore during the previous year ended March 2015. Sales declined 16.13% to Rs 2728.51 crore in the year ended March 2016 as against Rs 3253.41 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales686.06613.47 12 2728.513253.41 -16 OPM %18.7920.50 -17.5019.28 - PBDT153.04166.25 -8 599.18825.86 -27 PBT146.32161.50 -9 574.40800.51 -28 NP105.98102.85 3 375.21471.65 -20

Powered by Capital Market - Live News